In Lombardia the adoption of zoledronic could be cost effective when compared to other bisfosfonate in the treatment of postmenopausal osteoporosis
Autor: | Ulivieri, Fm, Baio, G, DI TANNA, GIAN LUCA, Integlia, D, Pammolli, F. |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2008 |
Databáze: | OpenAIRE |
Externí odkaz: |